AR078904A1 - Enantiomero 4r,5s de 2-(5-metil-2-oxo-4-fenil-pirrolidin-1-il)-acetamida con actividad nootropica - Google Patents

Enantiomero 4r,5s de 2-(5-metil-2-oxo-4-fenil-pirrolidin-1-il)-acetamida con actividad nootropica

Info

Publication number
AR078904A1
AR078904A1 ARP100104073A ARP100104073A AR078904A1 AR 078904 A1 AR078904 A1 AR 078904A1 AR P100104073 A ARP100104073 A AR P100104073A AR P100104073 A ARP100104073 A AR P100104073A AR 078904 A1 AR078904 A1 AR 078904A1
Authority
AR
Argentina
Prior art keywords
oxo
phenyl
methyl
enantiomer
atameter
Prior art date
Application number
ARP100104073A
Other languages
English (en)
Inventor
Maksims Vorona
Grigorijs Veinbergs
Maija Dombrova
Antons Lebedevs
Aleksandrs Cernobrovijs
Ivars Kalvins
Liga Zvejniece
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Publication of AR078904A1 publication Critical patent/AR078904A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Enantiomero-5S,4R de 2-(5-metil-2-oxo-4-fenil-pirrolidin-1-iI)-acetamida con actividad de mejoramiento de la cognicion y su método de preparacion, que incluye la síntesis de 5S-metil-4R-fenilpirrolidin-2-ona, su N-alquilacion con haloacetato de etilo y el tratamiento del intermediario etil acetato de 2-(5S-metll-2-oxo-4R-fenil-pirrolidin-1-iI) con amoníaco.
ARP100104073A 2009-11-05 2010-11-04 Enantiomero 4r,5s de 2-(5-metil-2-oxo-4-fenil-pirrolidin-1-il)-acetamida con actividad nootropica AR078904A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-09-193A LV14346B (lv) 2009-11-05 2009-11-05 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetamīda 4R,5S-enantiomērs ar nootropo aktivitāti

Publications (1)

Publication Number Publication Date
AR078904A1 true AR078904A1 (es) 2011-12-14

Family

ID=43466928

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100104073A AR078904A1 (es) 2009-11-05 2010-11-04 Enantiomero 4r,5s de 2-(5-metil-2-oxo-4-fenil-pirrolidin-1-il)-acetamida con actividad nootropica

Country Status (18)

Country Link
US (2) US8791273B2 (es)
EP (1) EP2496555B1 (es)
JP (1) JP2013510081A (es)
CN (1) CN102596905B (es)
AR (1) AR078904A1 (es)
CA (1) CA2780040C (es)
CY (1) CY1114881T1 (es)
DK (1) DK2496555T3 (es)
EA (1) EA019890B1 (es)
ES (1) ES2434024T3 (es)
HR (1) HRP20131086T1 (es)
LV (1) LV14346B (es)
PL (1) PL2496555T3 (es)
PT (1) PT2496555E (es)
RS (1) RS53014B (es)
SI (1) SI2496555T1 (es)
UA (1) UA107367C2 (es)
WO (1) WO2011054888A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3127539A1 (en) * 2015-08-03 2017-02-08 Latvian Institute Of Organic Synthesis Use of 2-(5s-methyl-2-oxo-4r-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures
RU2711655C1 (ru) * 2019-09-13 2020-01-20 Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации Способ крупномасштабного синтеза калиевой соли 2-[2-(2-оксо-4-фенилпирролидин-1-ил)ацетамидо]этансульфокислоты

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2186236B1 (es) * 1972-05-03 1975-08-01 Logeais Labor Jacques
CN1040747C (zh) * 1994-05-07 1998-11-18 中国科学院昆明植物研究所 N－取代基－4－取代苯基－5－烷基－5－取代苄基吡咯烷酮－2,其中间体,其合成方其法及应用
MXPA03005889A (es) * 2000-12-28 2005-02-14 Daiichi Seiyaku Co Agente para tratamiento terapeutico y profilactico del dolor neuropatico.
EP1698622B1 (en) * 2003-12-24 2010-03-03 Hideki Ohyama Treatment for severe aphasia in chronic-stage cerebrovascular disorder
GB0412019D0 (en) * 2004-05-28 2004-06-30 Novartis Ag Organic compounds
LV13630B (en) * 2006-03-16 2007-12-20 Olainfarm As Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone

Also Published As

Publication number Publication date
EP2496555B1 (en) 2013-08-28
CY1114881T1 (el) 2016-12-14
US8791273B2 (en) 2014-07-29
CA2780040A1 (en) 2011-05-12
JP2013510081A (ja) 2013-03-21
EA201200536A1 (ru) 2012-09-28
EP2496555A1 (en) 2012-09-12
US20140296317A1 (en) 2014-10-02
PL2496555T3 (pl) 2014-01-31
CN102596905A (zh) 2012-07-18
DK2496555T3 (da) 2013-11-11
HRP20131086T1 (hr) 2013-12-20
SI2496555T1 (sl) 2013-12-31
UA107367C2 (xx) 2014-12-25
LV14346B (lv) 2011-07-20
LV14346A (lv) 2011-05-20
CN102596905B (zh) 2014-07-16
US20120215010A1 (en) 2012-08-23
RS53014B (en) 2014-04-30
CA2780040C (en) 2014-04-08
WO2011054888A1 (en) 2011-05-12
EA019890B1 (ru) 2014-07-30
PT2496555E (pt) 2013-12-02
ES2434024T3 (es) 2013-12-13

Similar Documents

Publication Publication Date Title
EA201171293A1 (ru) 3-азабицикло[4.1.0]гептаны, применяемые в качестве антагонистов орексина
PH12014502613A1 (en) Synthesis of heterocyclic compound
CO6311079A2 (es) Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer
HN2012000263A (es) Derivados n1-sulfonil-5-fluoropirimidinona
ECSP12011654A (es) Derivados de 5-fluoropirimidinona
EA201290988A1 (ru) Стереоселективный синтез фосфорсодержащих активных соединений
EA201300669A1 (ru) Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение
EA201170356A1 (ru) Полиморфные и аморфные формы лакозамида и аморфные композиции
GT201200096A (es) Anticuerpos monoclonales
FR2946888B1 (fr) Procede de preparation de nacre mecanostructuree par mecano-synthese, nacre mecanostructuree ainsi obtenue et ses applications
BR112013007537A2 (pt) "processo de tratamento de biomassa"
ECSP12011653A (es) Derivados de n1-acil-5-fluoropirimidinona
MX2010010597A (es) Procesos para la preparacion de derivados de dioxina benzofusionados.
UY34420A (es) ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"
DK2595485T3 (da) Fremgangsmåder til anvendelse af cykliske amidderivater til behandling af sigma-receptormedierede forstyrrelser
CL2012003371A1 (es) Compuestos intermediarios de la síntesis de agomelatina; y el procedimiento de obtención de agomelatina a partir de dichos compuestos intermediarios
IN2012DN03379A (es)
AR078904A1 (es) Enantiomero 4r,5s de 2-(5-metil-2-oxo-4-fenil-pirrolidin-1-il)-acetamida con actividad nootropica
IL207668A0 (en) Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
EA201170422A1 (ru) Органические соли питательных веществ, способы получения и применения
UY32447A (es) Derivados de 3-benzofuranilindol-2-ona sustituidos en 3, su preparacion y su aplicacion en terapia
BR112012024817A2 (pt) processo de preparação de uma lactona, catalisador de hidrogenação de ciclização e utilização
TN2012000381A1 (en) 2-aldoximino-5-fluoropyrimidine derivatives
MX2013002485A (es) Fenilacetamidas y fenilpropanamidas sustituidas y su uso.
RS20100352A2 (en) METHOD OF PREPARATION AND USE OF PHARMACOLOGICAL ACTIVE N-CARBAMYLMETHYL-4 (R) -Phenyl-2-Pyrrolidinone

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FB Suspension of granting procedure